August 16, 2012

APIM Therapeutics has been selected to present at the 12th Biotech In Europe Investor Forum. The conference, which takes place in October 1-2, 2012 in Zurich, brings together venture-funded and small-cap companies with leading investors, pharmas, and scientific thought leaders.

March 15, 2012

APIM Therapeutics will present a poster entitled "A novel APIM-motif comprising peptide drug potentiates the action of several chemotherapeutic drugs by blocking the interaction between PCNA and key proteins involved in DNA repair, apoptosis and cell cycle control" at the Annual Meeting of the American Cancer Association (AACR), taking place in Chicago, USA (March 31- April 4). The poster (#4676) will be presented on Tuesday, April 03, at the poster session 30, Hall F, 1:00 pm - 5:00 pm.

January 5, 2012

A panel of industry experts has selected APIM Therapeutics to present at BIO-Europe Spring 2012, the springtime counterpart to BIO-Europe. The conference, which takes place in March 19–21, 2012 in Amsterdam, focuses on biotechnology companies interested in partnering their technologies or products, initiating strategic alliances, or tapping into the international financing network.